Investigational pharmacological agents for the treatment of ARDS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational pharmacological agents for the treatment of ARDS

Published:2024-02-27 Issue:3 Volume:33 Page:243-277
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Aribindi Katyayini¹²,Lim Michelle³,Lakshminrusimha Satyan⁴,Albertson Timothy¹^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, U.C. Davis School of Medicine, Sacramento, CA, USA

2. Department of Medicine, Veterans Affairs North California Health Care System, Mather, CA, USA

3. Department of Pediatrics, Division of Pediatric Critical Care Medicine, U.C. Davis School of Medicine, Sacramento, CA, USA

4. Department of Pediatrics, Division of Neonatal-Perinatal Medicine, U.C. Davis School of Medicine, Sacramento, CA, USA

Funder

NHLBI funded T32 post-doctoral fellowship to Katyayini Aribindi

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2315128

Reference298 articles.

1. ACUTE RESPIRATORY DISTRESS IN ADULTS

2. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

3. Validating Measures of Disease Severity in Acute Respiratory Distress Syndrome

4. The Association Between Etiologies and Mortality in Acute Respiratory Distress Syndrome: A Multicenter Observational Cohort Study

5. Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral diffuse alveolar damage contributes to the fatal toxicity of pre-existing interstitial lung disease mice after partial thoracic irradiation;2024-08-28

2. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS);International Journal of Pharmaceutics;2024-05

3. Application of Nanobiomedicine in Acute Lung Injury;Journal of Biomaterials and Tissue Engineering;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3